PD-L1, a Master Regulator of Immunity 2.0

por Kochan, Grazyna
Publicado 2023

Cell and Tissue Gene Targeting with Lentiviral Vectors

por Escors, David, Kochan, Grazyna, Stephenson, Holly, Breckpot, Karine
Publicado 2012

Role of non-classical MHC class I molecules in cancer immunosuppression

por Kochan, Grazyna, Escors, David, Breckpot, Karine, Guerrero-Setas, David
Publicado 2013

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies

por Arasanz, Hugo, Zuazo, Miren, Vera, Ruth, Kochan, Grazyna, Escors, David
Publicado 2018

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats

por Echaide, Miriam, Chocarro de Erauso, Luisa, Bocanegra, Ana, Blanco, Ester, Kochan, Grazyna, Escors, David
Publicado 2023

PD1 signal transduction pathways in T cells

por Arasanz, Hugo, Gato-Cañas, Maria, Zuazo, Miren, Ibañez-Vea, Maria, Breckpot, Karine, Kochan, Grazyna, Escors, David
Publicado 2017

Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy

por Zuazo, Miren, Arasanz, Hugo, Bocanegra, Ana, Chocarro, Luisa, Vera, Ruth, Escors, David, Kagamu, Hiroshi, Kochan, Grazyna
Publicado 2020

Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy

por Zuazo, Miren, Arasanz, Hugo, Bocanegra, Ana, Fernandez, Gonzalo, Chocarro, Luisa, Vera, Ruth, Kochan, Grazyna, Escors, David
Publicado 2020

The intracellular signalosome of PD-L1 in cancer cells

por Escors, David, Gato-Cañas, María, Zuazo, Miren, Arasanz, Hugo, García-Granda, María Jesus, Vera, Ruth, Kochan, Grazyna
Publicado 2018

Oxygenase-Catalyzed Desymmetrization of N,N-Dialkyl-piperidine-4-carboxylic Acids**

por Rydzik, Anna M, Leung, Ivanhoe K H, Kochan, Grazyna T, McDonough, Michael A, Claridge, Timothy D W, Schofield, Christopher J
Publicado 2014

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies

por Hernandez, Carlos, Arasanz, Hugo, Chocarro, Luisa, Bocanegra, Ana, Zuazo, Miren, Fernandez-Hinojal, Gonzalo, Blanco, Ester, Vera, Ruth, Escors, David, Kochan, Grazyna
Publicado 2020

PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy

por Bocanegra, Ana, Blanco, Ester, Fernandez-Hinojal, Gonzalo, Arasanz, Hugo, Chocarro, Luisa, Zuazo, Miren, Morente, Pilar, Vera, Ruth, Escors, David, Kochan, Grazyna
Publicado 2020

Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy

por Escors, David, Bocanegra, Ana, Chocarro, Luisa, Blanco, Ester, Piñeiro-Hermida, Sergio, Garnica, Maider, Fernandez-Rubio, Leticia, Vera, Ruth, Arasanz, Hugo, Kochan, Grazyna
Publicado 2022

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors

por Blanco, Ester, Chocarro, Luisa, Fernández-Rubio, Leticia, Bocanegra, Ana, Arasanz, Hugo, Echaide, Miriam, Garnica, Maider, Piñeiro-Hermida, Sergio, Kochan, Grazyna, Escors, David
Publicado 2023

Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events

por Les, Iñigo, Martínez, Mireia, Pérez-Francisco, Inés, Cabero, María, Teijeira, Lucía, Arrazubi, Virginia, Torrego, Nuria, Campillo-Calatayud, Ana, Elejalde, Iñaki, Kochan, Grazyna, Escors, David
Publicado 2023

Structural Basis for Substrate Specificity in Human Monomeric Carbonyl Reductases

por Pilka, Ewa S., Niesen, Frank H., Lee, Wen Hwa, El-Hawari, Yasser, Dunford, James E., Kochan, Grazyna, Wsol, Vladimir, Martin, Hans-Joerg, Maser, Edmund, Oppermann, Udo
Publicado 2009

Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

por Merino, María, Lozano, Teresa, Casares, Noelia, Lana, Hugo, Troconiz, Iñaki F., ten Hagen, Timo L. M., Kochan, Grazyna, Berraondo, Pedro, Zalba, Sara, Garrido, María J.
Publicado 2021

Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions

por Lachén-Montes, Mercedes, Mendizuri, Naroa, Ausín, Karina, Echaide, Miriam, Blanco, Ester, Chocarro, Luisa, de Toro, María, Escors, David, Fernández-Irigoyen, Joaquín, Kochan, Grazyna, Santamaría, Enrique
Publicado 2022

Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer

por Arasanz, Hugo, Chocarro, Luisa, Fernández-Rubio, Leticia, Blanco, Ester, Bocanegra, Ana, Echaide, Miriam, Labiano, Ibone, Huerta, Ana Elsa, Alsina, Maria, Vera, Ruth, Escors, David, Kochan, Grazyna
Publicado 2023

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?

por Chocarro de Erauso, Luisa, Zuazo, Miren, Arasanz, Hugo, Bocanegra, Ana, Hernandez, Carlos, Fernandez, Gonzalo, Garcia-Granda, Maria Jesus, Blanco, Ester, Vera, Ruth, Kochan, Grazyna, Escors, David
Publicado 2020